Pyrophyte Acquisition Corp (PHYT) News

ASML Rises 7% on Export Waiver; Intel Plans Layoffs, HSBC $3B Buyback Announced, and More

ASML Holding NV (NASDAQ:ASML) – Semiconductor stocks rose globally after news that the US will exempt...

Futures Pointing To Another Lackluster Session On Wall Street

The major U.S. index futures are currently pointing to a roughly flat open on Tuesday, with stocks likely to...

Form 8-K - Current report

Merck Announces Second-Quarter 2024 Financial Results

Total Worldwide Sales Were $16.1 Billion, an Increase of 7% From Second Quarter 2023; Excluding the Impact of Foreign Exchange, Growth Was 11...

U.S. Futures Climb Before Fed Meeting; Oil Prices Drop on China Demand Worries

U.S. index futures rose slightly in pre-market trading on Tuesday, with major corporate earnings and the start...

F5 Shares Rise 15%; Diageo Falls 10% on Annual Sales Decline; BP Boosts Dividend and Buyback Program

F5 (NASDAQ:FFIV) – The security and networking solutions company reported adjusted earnings of $3.36 per...

U.S. Stocks Finish Choppy Trading Session Little Changed

Stocks moved to the upside early in the session on Monday but showed a lack of direction over the course of...

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma

Opinion granted based on positive overall survival and progression-free survival results from the Phase 3 KEYNOTE-A39 trial Positive opinion...

Merck Announces Fourth-Quarter 2024 Dividend

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly...

Merck Announces Topline Results from Phase 2b/3 Trial of Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus Preventative Monoclonal Antibody for Infants

Clesrovimab met all primary safety and efficacy endpoints Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today...

Merck to Share New Research and Host Community-Focused Symposia at AIDS 2024

Symposia will highlight work to overcome HIV-related stigma and discuss the evolving state of HIV treatment and prevention Merck (NYSE: MRK...

Merck Completes Acquisition of EyeBio

Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret™, a novel late-phase candidate for diabetic macular edema...

Merck Animal Health Completes Acquisition of Elanco’s Aqua Business

Acquisition delivers industry-leading portfolio, scientific and research capabilities, for enhanced customer benefits Merck Animal Health, known...

Elanco Completes Sale of Aqua Business

Elanco Completes Sale of Aqua Business PR Newswire GREENFIELD, Ind., July 9, 2024 Transaction concentrates...

Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Orion Corporation (“Orion”) today announced that notice has been...